Tetanus toxoid‐loaded transfersomes for topical immunization
暂无分享,去创建一个
A. Rawat | S. Mahor | S. Vyas | Paramjit Singh | Prem N. Gupta | V. Mishra | S. P. Vyas | P. Dubey | P. Gupta
[1] Y. Y. Wang,et al. Effect of liposomes and niosomes on skin permeation of enoxacin. , 2001, International journal of pharmaceutics.
[2] P. Wertz,et al. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. , 2001, International journal of pharmaceutics.
[3] Y. Maa,et al. Adjuvantation of epidermal powder immunization. , 2001, Vaccine.
[4] C. Alving,et al. Transcutaneous immunization: A human vaccine delivery strategy using a patch , 2000, Nature Medicine.
[5] J. Breul,et al. New Ultradeformable Drug Carriers for Potential Transdermal Application of Interleukin-2 and Interferon-a Theoretic and Practical Aspects , 2000, World Journal of Surgery.
[6] C. Valenta,et al. Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[7] Andreas G. Schätzlein,et al. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. , 1998, Biochimica et biophysica acta.
[8] M. Iwaki,et al. Mechanism for enhancement effect of lipid disperse system on percutaneous absorption : Part II , 1997 .
[9] A. Schätzlein,et al. TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES , 1995 .
[10] N. Weiner,et al. Liposomes as carriers for topical and transdermal delivery. , 1994, Journal of pharmaceutical sciences.
[11] G. Cevc,et al. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.
[12] T. Kupper. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. , 1990, The Journal of clinical investigation.
[13] P. Bergstresser,et al. Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness. , 1990, Dermatologic clinics.
[14] N. Weiner,et al. Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model , 1989, Antimicrobial Agents and Chemotherapy.
[15] R. Warner,et al. Electron probe analysis of human skin: determination of the water concentration profile. , 1988, The Journal of investigative dermatology.
[16] P. Das,et al. The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. , 1987, The Journal of investigative dermatology.
[17] W. Silvers,et al. Distribution of ATPase‐positive Langerhans cells in normal adult human skin , 1985, The British journal of dermatology.
[18] A. Florence,et al. The preparation and properties of niosomes—non‐ionic surfactant vesicles , 1985, The Journal of pharmacy and pharmacology.
[19] H. Kiwada,et al. Tissue distribution and pharmacokinetic evaluation of the targeting efficiency of synthetic alkyl glycoside vesicles. , 1985, Chemical & pharmaceutical bulletin.
[20] R. Steinman,et al. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro , 1985, The Journal of experimental medicine.
[21] R. Handjani-Vila,et al. Dispersions of lamellar phases of non‐ionic lipids in cosmetic products , 1979, International journal of cosmetic science.
[22] J. White,et al. Rapid separation of low molecular weight solutes from liposomes without dilution. , 1978, Analytical biochemistry.
[23] Sanyog Jain,et al. Topical immunization: Mechanistic insight and novel delivery systems , 2004 .
[24] Myron M. Levine,et al. Can needle-free administration of vaccines become the norm in global immunization? , 2003, Nature Medicine.
[25] L. Simonsen,et al. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. , 1999, Bulletin of the World Health Organization.
[26] G. Cevc,et al. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. , 1998, Vaccine.
[27] M. Udey. Cadherins and Langerhans cell immunobiology. , 1997, Clinical and experimental immunology.
[28] T. Kissel,et al. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. , 1992, Vaccine.